In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine study has concluded that there could be a significant impact on cognitive ...

Reducing intravenous (IV) isatuximab delivery from 75 minutes to 30 minutes could provide a wealth of benefits to patients ...

Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug Application (NDA) Submission Anticipated First Half of ...

Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug ...

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Financing led by Nantahala Capital and ADAR1 Partners, LP with participation from new and existing healthcare-focused institutional investors$15 ...

Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine. New Drug Application (NDA) Submission Expected in the ...

"After seven days of sweating and shivering, with a raging temperature and chills, and pain in my chest and back, my wee ...

On January 22, 2025, the Lions Club of Penetanguishene presented a cheque for $5,200 to Victoria Evans, community Giving ...

Fact checked by Nick Blackmer NAD+ injection is the latest longevity hack to sweep Hollywood. Celebrities like Hailey Bieber ...

Celebrities and wellness influencers are getting routine NAD+ infusions as an anti-aging hack, but are these expensives IV ...

GREENFIELD — Sue Ann Wortman Cancer Center is doubling the size of its infusion center, where patients receive chemotherapy ...